The recent disruptions in global supply have highlighted the value of securing critical medications like Ivermectin. Dependence on overseas manufacturers exposes regions to potential vulnerabilities, including shipping delays, price fluctuations, and even political concerns. Transitioning towards domestic procurement of Ivermectin offers a multitud